A new PSO-based algorithm for multi-objective optimization with continuous and discrete design variables

This paper presents a new multi-objective optimization algorithm called FC-MOPSO for optimal design of engineering problems with a small number of function evaluations. The proposed algorithm expands the main idea of the single-objective particle swarm optimization (PSO) algorithm to deal with constrained and unconstrained multi-objective problems (MOPs). FC-MOPSO employs an effective procedure in selection of the leader for each particle to ensure both diversity and fast convergence. Fifteen benchmark problems with continuous design variables are used to validate the performance of the proposed algorithm. Finally, a modified version of FC-MOPSO is introduced for handling discrete optimization problems. Its performance is demonstrated by optimizing five space truss structures. It is shown that the FC-MOPSO can effectively find acceptable approximations of Pareto fronts for structural MOPs within very limited number of function evaluations.     

Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study

This paper describes the production, purification, and immobilization of l-asparaginase II (ASNase II) in chitosan nanoparticles (CSNPs). ASNase II is an effective antineoplastic agent, used in the acute lymphoblastic leukemia chemotherapy. Cloned ASNase II gene (ansB) in pAED4 plasmid was transformed into Escherichia coli BL21pLysS (DE3) competent cells and expressed under optimal conditions. The lyophilized enzyme was loaded into CSNPs by ionotropic gelation method. In order to get optimal entrapment efficiency, CSNP preparation, chitosan/tripolyphosphate (CS/TPP) ratio, and protein loading were investigated. ASNase II loading into CSNPs was confirmed by Fourier transform infrared (FTIR) spectroscopy, and morphological observation was carried out by transmission electron microscopy. Three absolute CS/TPP ratios were studied. Entrapment efficiency and loading capacity increased with increasing CS and TPP concentration. The best ratio was applied for obtaining optimal ASNase II-loaded CSNPs with the highest entrapment efficiency. Size, zeta potential, entrapment efficiency, and loading capacity of the optimal ASNase II-CSNPs were 340 ± 12 nm, 21.2 ± 3 mV, 76.2% and 47.6%, respectively. The immobilized enzyme showed an increased in vitro half-life in comparison with the free enzyme. The pH and thermostability of the immobilized enzyme was comparable with the free enzyme. This study leads to a better understanding of how to prepare CSNPs, how to achieve high encapsulation efficiency for a high molecular weight protein, and how to prolong the release of protein from CSNPs. A conceptual understanding of biological responses to ASNase II-loaded CSNPs is needed for the development of novel methods of drug delivery.     

Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)

Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines.     

A Mutation in DNA Polymerase α Rescues WEE1KO Sensitivity to HU

During DNA replication, the WEE1 kinase is responsible for safeguarding genomic integrity by phosphorylating and thus inhibiting cyclin-dependent kinases (CDKs), which are the driving force of the cell cycle. Consequentially, wee1 mutant plants fail to respond properly to problems arising during DNA replication and are hypersensitive to replication stress. Here, we report the identification of the polα-2 mutant, mutated in the catalytic subunit of DNA polymerase α, as a suppressor mutant of wee1. The mutated protein appears to be less stable, causing a loss of interaction with its subunits and resulting in a prolonged S-phase.     

Experimental and numerical study of distortion in flat,L‐shaped,and U‐shaped carbon fiber–epoxy composite parts

In this study, flat composite panels were fabricated to find the effect of different manufacturing parameters, including stacking sequence, part thickness, and tooling material, on distortion of carbon fiber‐epoxy composite parts. L‐shaped and U‐shaped panels were also made to investigate the effect of stacking sequence on spring‐in angle and warpage of the curved panels. Results showed that distortion of the flat panels caused by asymmetry in the stacking sequence was an order of magnitude greater than distortion of the panels with an unbalanced stacking sequence; whereas in the curved panels, the panel with an asymmetric stacking sequence showed the least spring‐in angle, and the largest angle was observed in the symmetric panel. MSC Marc was used to predict distortion of the panels, and the simulation results were compared with the experimental results for several stacking sequences of the flat and the L‐shaped panels. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 40439.     

A Cyber-Kill-Chain based taxonomy of crypto-ransomware features

Journal of Computer Virology and Hacking Techniques - In spite of being just a few years old, ransomware is quickly becoming a serious threat to our digital infrastructures, data and services....     

Investigation of palladium-103 production and IR07-Pd brachytherapy seed preparation

In this study, design and fabrication of ¹⁰³Pd brachytherapy seed was investigated. The excitation functions of ¹⁰³Rh(p,n)¹⁰³Pd and ¹⁰³Rh(d,2n)¹⁰³Pd reactions were calculated using EMPIRE (version 3.1 Rivoli), ALICE/ASH and TALYS-1.2 codes, the TENDL-2010 database and compared with the published data. Production of ¹⁰³Pd was done via ¹⁰³Rh(p,n)¹⁰³Pd nuclear reaction. The target was bombarded with 18 MeV protons at 200 μA beam current for 15 h. After irradiation and radiochemical separation of the electroplated rhodium target, the optimum condition for absorption of ¹⁰³Pd into Amberlite®IR-93 resin was achieved at 0.5 M HCl. Version 5 of the (MCNP) Monte Carlo radiation transport code was employed to calculate the dosimetric parameters around the ¹⁰³Pd brachytherapy seed. Finally the calculated results were compared with published results for other commercial sources.